201 related articles for article (PubMed ID: 10662250)
1. Ocular manifestations of systemic malignancies.
Solomon SD; Smith JH; O'Brien J
Curr Opin Ophthalmol; 1999 Dec; 10(6):447-51. PubMed ID: 10662250
[TBL] [Abstract][Full Text] [Related]
2. [Intraocular manifestations of systemic neoplasms].
Bechrakis NE; Haas G; Blatsios G
Klin Monbl Augenheilkd; 2011 Jul; 228(7):586-92. PubMed ID: 21739400
[TBL] [Abstract][Full Text] [Related]
3. [Ocular manifestations of cancer].
De Potter P; Disneur D; Levecq L; Snyers B
J Fr Ophtalmol; 2002 Feb; 25(2):194-202. PubMed ID: 11941243
[TBL] [Abstract][Full Text] [Related]
4. [Paraneoplastic Syndromes in Ophthalmology (French version of the article)].
Bussat A; Langner-Lemercier S; Salmon A; Mouriaux F
J Fr Ophtalmol; 2018 Jun; 41(6):554-559. PubMed ID: 29891101
[TBL] [Abstract][Full Text] [Related]
5. Ocular manifestations of cancer.
De Potter P
Curr Opin Ophthalmol; 1998 Dec; 9(6):100-4. PubMed ID: 10387328
[TBL] [Abstract][Full Text] [Related]
6. [Intraocular manifestations of systemic cancer].
Caminal-Mitjana JM
Rev Neurol; 2000 Dec 16-31; 31(12):1259-61. PubMed ID: 11205572
[TBL] [Abstract][Full Text] [Related]
7. Ocular manifestations of malignant disease.
Rennie IG
Br J Hosp Med; 1992 Feb 5-18; 47(3):185-6, 188, 190-1. PubMed ID: 1543973
[TBL] [Abstract][Full Text] [Related]
8. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.
Khan N; Huang JJ; Foster CS
Semin Ophthalmol; 2006; 21(3):135-41. PubMed ID: 16912011
[TBL] [Abstract][Full Text] [Related]
9. Malignant uveitis masquerade syndromes.
Kubicka-Trzaska A; Romanowska-Dixon B
Klin Oczna; 2008; 110(4-6):199-202. PubMed ID: 18655462
[TBL] [Abstract][Full Text] [Related]
10. Ocular syndromes associated with systemic malignancy.
Amin AR; Jakobiec FA; Dreyer EB
Int Ophthalmol Clin; 1997; 37(4):281-302. PubMed ID: 9429947
[No Abstract] [Full Text] [Related]
11. Paraneoplastic syndromes associated with visual loss.
Ling CP; Pavesio C
Curr Opin Ophthalmol; 2003 Dec; 14(6):426-32. PubMed ID: 14615650
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic retinopathies and optic neuropathies.
Chan JW
Surv Ophthalmol; 2003; 48(1):12-38. PubMed ID: 12559325
[TBL] [Abstract][Full Text] [Related]
13. The kidney, cancer, and the eye: current concepts.
Kurli M; Finger PT
Surv Ophthalmol; 2005; 50(6):507-18. PubMed ID: 16263367
[TBL] [Abstract][Full Text] [Related]
14. Ocular manifestations of various systemic disorders.
Mansour AM
Curr Opin Ophthalmol; 1994 Dec; 5(6):105-9. PubMed ID: 10150822
[TBL] [Abstract][Full Text] [Related]
15. [Severe visual loss caused by autoimmune retinopathy].
ten Berge JC; Schreurs MW; Dufour-van den Goorbergh BC; de Witte PM; van Schooneveld MJ; Rothova A
Ned Tijdschr Geneeskd; 2015; 159():A8039. PubMed ID: 25654680
[TBL] [Abstract][Full Text] [Related]
16. Choroidal neovascularization associated with cancer-associated retinopathy.
Querques G; Thirkill CE; Hagege H; Soubrane G; Souied EH
Acta Ophthalmol; 2010 Aug; 88(5):571-5. PubMed ID: 19141145
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic disorders of neuro-ophthalmologic interest.
Jacobson DM
Curr Opin Ophthalmol; 1996 Dec; 7(6):30-8. PubMed ID: 10166550
[TBL] [Abstract][Full Text] [Related]
18. Neoplastic masquerade syndromes.
Read RW; Zamir E; Rao NA
Surv Ophthalmol; 2002; 47(2):81-124. PubMed ID: 11918892
[TBL] [Abstract][Full Text] [Related]
19. [The eye and cancer].
Schalenbourg A; Mantel I
Rev Med Suisse; 2015 Dec; 11(499):2395-8. PubMed ID: 26852556
[TBL] [Abstract][Full Text] [Related]
20. Immunopathogenesis of ophthalmological paraneoplastic syndromes: Recent findings.
Kordyś M; Przeździecka-Dołyk J; Turno-Kręcicka A; Misiuk-Hojło M
Adv Clin Exp Med; 2018 Oct; 27(10):1431-1439. PubMed ID: 30289210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
